DEA, HHS: Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

Federal Register

Nov 19, 2024

Notice from the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) issuing a temporary rule to extend certain exceptions to existing DEA regulations implemented in March 2020 because of the COVID-19 Public Health Emergency (COVID-19 PHE). The full set of telemedicine flexibilities regarding the prescription of controlled medications that were in place during the COVID-19 PHE as outlined in the Second Temporary Rule will remain in place through December 31, 2025. This rule is effective January 1, 2025, through December 31, 2025.

Access · Behavioral health · COVID-19 · Health workforce · Legislation and regulations · Pharmacy and prescription drugs · Telehealth